Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab ProphylaxisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorderRecruitingNot stated2026-07-02NCT05022459

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genentech, Inc.221
Wayne State University56

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Arkansas Children's HospitalLittle RockUnited States82
Boston Children's HospitalBostonUnited States20
Children's Hospital of MichiganDetroitUnited States73
Cincinnati Children's Hospital Medical CenterCincinnatiUnited States405
Indiana Hemophilia & Thrombosis centerIndianapolisUnited States3
Johns Hopkins All Children's HospitalSt. PetersburgUnited States116
Oklahoma Center for Bleeding and Clotting DisordersOklahoma CityUnited States2
Rady Children's HospitalSan DiegoUnited States52
Rush University Children's HospitalChicagoUnited States2
Stanford UniversityPalo AltoUnited States161